Phase I Study of Tivantinib Plus Bevacizumab
Phase of Trial: Phase I
Latest Information Update: 16 Oct 2017
At a glance
- Drugs Tivantinib (Primary) ; Bevacizumab
- Indications Solid tumours
- Focus Adverse reactions
- 11 Oct 2017 Status changed from active, no longer recruiting to completed.
- 03 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Jan 2013 New trial record